Prices are updated after-hours


Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date

tags : Approval    symbols : BLUE    save search

bluebird bio Announces FDA Approval of LYFGENIA™ (lovotibeglogene autotemcel) for Patients Ages 12 and Older with Sickle Cell Disease and a History of Vaso-Occlusive Events
Published: 2023-12-08 (Crawled : 22:00) - biospace.com/
BLUE | $0.9229 -4.91% -4.66% 7.9M twitter stocktwits trandingview |
Health Technology
| | O: 6.03% H: 8.43% C: -43.92%

fda disease approval cell
bluebird bio Announces FDA Approval of ZYNTEGLO®, the First Gene Therapy for People with Beta-Thalassemia Who Require Regular Red Blood Cell Transfusions
Published: 2022-08-17 (Crawled : 22:00) - biospace.com/
BLUE | $0.9229 -4.91% -4.66% 7.9M twitter stocktwits trandingview |
Health Technology
| | O: -4.41% H: 30.05% C: 7.79%

zynteglo fda blood approval therapy
Global $21.2 Bn Advanced Therapy Medicinal Products Market to 2028: Breakthrough Approvals of Tecartus and Abecma Post-approval of Zolgensma, Kymriah, and Yescarta have Bolstered Rapid Advancements
Published: 2021-09-23 (Crawled : 12:00) - prnewswire.com
NVS | News | $98.35 1.1% 0.69% 2.1M twitter stocktwits trandingview |
Health Technology
| | O: 0.92% H: 0.5% C: 0.01%
BMY | $48.86 -0.27% 0.98% 14M twitter stocktwits trandingview |
Health Technology
| | O: 0.42% H: 1.55% C: 0.38%
VCEL | $46.11 -0.67% -0.72% 200K twitter stocktwits trandingview |
Health Technology
| | O: 0.86% H: 2.12% C: 1.89%
QURE | $4.56 -4.0% -3.94% 640K twitter stocktwits trandingview |
Health Technology
| | O: 0.5% H: 0.58% C: -5.62%
BLUE | $0.9229 -4.91% -4.66% 7.9M twitter stocktwits trandingview |
Health Technology
| | O: 1.11% H: 2.8% C: 2.53%
BIIB | $201.99 4.56% 4.32% 2.7M twitter stocktwits trandingview |
Health Technology
| | O: 1.51% H: 2.09% C: -0.17%

therapy approval
bluebird bio Receives EC Approval for SKYSONA™ (elivaldogene autotemcel, Lenti-D™) Gene Therapy for Patients Less Than 18 Years of Age With Early Cerebral Adrenoleukodystrophy (CALD) Without Matched Sibling Donor
Published: 2021-07-21 (Crawled : 11:00) - biospace.com/
BLUE | $0.9229 -4.91% -4.66% 7.9M twitter stocktwits trandingview |
Health Technology
| | O: 0.7% H: 1.6% C: -0.11%

gene therapy therapy approval gene therapies
Gainers vs Losers
61% 39%

Top 10 Gainers
CSSE 4 | $0.4253 179.25% 64.77% 210M twitter stocktwits trandingview |
Consumer Services

BOF | $2.08 77.78% 41.21% 110M twitter stocktwits trandingview |

ILAG | $0.54 12.27% 40.62% 3.7M twitter stocktwits trandingview |

LICN | $0.999 78.39% 40.49% 15M twitter stocktwits trandingview |

AMST | $3.4 70.0% 39.58% 70M twitter stocktwits trandingview |
Technology Services

MTC | $3.6 60.71% 38.04% 9.1M twitter stocktwits trandingview |
Technology Services

WIMI | $1.15 58.53% 36.92% 19M twitter stocktwits trandingview |
Technology Services

AIH | $0.458 14.5% 30.92% 91K twitter stocktwits trandingview |
Health Services

WHLM | $6.25 35.87% 28.46% 700K twitter stocktwits trandingview |
Commercial Services

MULN | News | $3.77 38.1% 27.78% 13M twitter stocktwits trandingview |
Information


Your saved searches
Save your searches and get alerts when important news are released.